Levofloxacin pharmacokinetics/pharmacodynamics, dosing, susceptibility breakpoints, and artificial intelligence in the treatment of multidrug-resistant tuberculosis

Levofloxacin pharmacokinetics/pharmacodynamics, dosing, susceptibility breakpoints, and artificial intelligence in the treatment of multidrug-resistant tuberculosis

<p><strong>Background</strong> Levofloxacin is used for the treatment of multidrug-resistant tuberculosis; however the optimal dose is unknown.</p> <p><strong>Methods</strong> We used the hollow fiber system model of tuberculosis (HFS-TB) to identify 0–24 h...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Deshpande, D, Pasipanodya, JG, Mpagama, SG, Bendet, P, Srivastava, S, Koeuth, T, Lee, PS, Bhavnani, SM, Ambrose, PG, Thwaites, G, Heysell, SK, Gumbo, T
Natura:	Journal article
Lingua:	English
Pubblicazione:	Oxford University Press 2018
Soggetti:	lung artificial intelligence mutation minimum inhibitory concentration result minimum inhibitory concentration measurement pharmacokinetics pharmacodynamics exposure pulmonary tuberculosis tuberculosis levofloxacin moxifloxacin tuberculous meningitis multidrug-resistant tuberculosis probit trial

Documenti analoghi

Wild-Type MIC Distribution for Re-evaluating the Critical Concentration of Anti-TB Drugs and Pharmacodynamics Among Tuberculosis Patients From South India
di: Azger Dusthackeer, et al.
Pubblicazione: (2020-06-01)

Efflux-mediated resistance identified among norfloxacin resistant clinical strains of group B from South Korea
di: Trang Nguyen Doan Dang, et al.
Pubblicazione: (2014-10-01)

Discordance in genotypic and phenotypic drug susceptibility results: time to reconsider critical concentration of rifampicin
di: Arti Shrivas, et al.
Pubblicazione: (2025-03-01)

Benzothiazinone-piperazine derivatives as efficient Mycobacterium tuberculosis DNA gyrase inhibitors
di: Manoj Chandran, et al.
Pubblicazione: (2015-01-01)

Novel oxazolidinones harbor potent in vitro activity against the clinical isolates of multidrug-resistant Mycobacterium tuberculosis in China
di: Chenqian Wang, et al.
Pubblicazione: (2022-11-01)

Stratifying low level Isoniazid resistance using additional intermediate drug concentration
di: Rajagopalan Lakshmi, et al.
Pubblicazione: (2014-01-01)

What’s the Matter with MICs: Bacterial Nutrition, Limiting Resources, and Antibiotic Pharmacodynamics
di: Brandon A. Berryhill, et al.
Pubblicazione: (2023-06-01)

The ethanolic extract of ashitaba stem (Angelica keskei [Miq.] Koidz) as future antituberculosis
di: Sri Agung Fitri Kusuma, et al.
Pubblicazione: (2018-01-01)

EXPERIENCE OF USING THE MINIMUM INHIBITORY CONCENTRATION METHOD ON LIQUID NUTRITIONAL MEDIA FOR DRUG SUSCEPTIBILITY TESTING OF NON-TUBERCULOUS MYCOBACTERIA
di: O. I. Alkhovik, et al.
Pubblicazione: (2017-09-01)

Different Contributions of embB and ubiA Mutations to Variable Level of Ethambutol Resistance in Mycobacterium tuberculosis Isolates
di: Nan XT, et al.
Pubblicazione: (2024-07-01)

Drug Exposure and Susceptibility of Pyrazinamide Correlate with Treatment Response in Pyrazinamide-Susceptible Patients with Multidrug-Resistant Tuberculosis
di: Shulan Dong, et al.
Pubblicazione: (2024-01-01)

In Vitro Activity of Vancomycin and Teicoplanin Against Coagulase Negative Staphylococci
di: Vishal Sharma, et al.
Pubblicazione: (2011-05-01)

Evaluation of resistance rates of enterobacterales to beta-lactam drugs and interpretation of their minimum inhibitory concentrations relative to clinical breakpoints
di: Uma BM, et al.
Pubblicazione: (2024-07-01)

Susceptibility of Selected Multi-Drug Resistant Clinical Isolates to Different Leaf Extracts of Senna alata
di: Ibikunle Ibitayo ANIBIJUWON, et al.
Pubblicazione: (2018-03-01)

Correlation of Minimum Inhibitory Concentration Breakpoints and Methicillin Resistance Gene Carriage in Clinical Isolates of Staphylococcus epidermidis
di: Fereshteh Eftekhar,, et al.
Pubblicazione: (2011-09-01)

Mycobacterium tuberculosis Strains H37ra and H37rv have equivalent minimum inhibitory concentrations to most antituberculosis drugs
di: Marc Tobias Heinrichs, et al.
Pubblicazione: (2018-01-01)

Evaluation of Antimicrobial Efficacy of Ethanol Extracts of Fresh <i>Citrus sinensis</i> (Sweet Orange) Seeds against Selected Bacterial Strains
di: E.I. Oikeh, et al.
Pubblicazione: (2020-04-01)

Antifungal Activity of Ephedra major Extract against Candida Albicans (ATC1677), Candida Tropicalis (CBS94), and Candida Globrata (CBS2175)
di: Faranak Bidad, et al.
Pubblicazione: (2023-08-01)

The In vitro Study of Antimicrobial Effect of Teucrium polium Extract on Infectious Microorganisms
di: Farideh Tabatabaei Yazdi, et al.
Pubblicazione: (2014-06-01)

Antimicrobial activity, total phenolic content and flavonoid concentrations of Teucrium species
di: Stanković Milan, et al.
Pubblicazione: (2012-08-01)

The first assessment of antimicrobial sensitivity of Mycoplasma gallisepticum and M. synoviae from laying hens in Brazil
di: D.S. Fialho, et al.
Pubblicazione: (2025-01-01)

Antibacterial Activity of the Pyrogallol against <i>Staphylococcus aureus</i> Evaluated by Optical Image
di: Lígia C. C. Oliveira, et al.
Pubblicazione: (2022-05-01)

Biosynthesis of Silver Nanoparticles Using Bacteria Isolates from Wastewater
di: Shima Kazemi, et al.
Pubblicazione: (2017-11-01)

Novel Pharmacokinetic/Pharmacodynamic Parameters Quantify the Exposure–Effect Relationship of Levofloxacin against Fluoroquinolone-Resistant <i>Escherichia coli</i>
di: Johanna Seeger, et al.
Pubblicazione: (2021-05-01)

Comparative growth kinetics and drug susceptibility of Mycobacterium tuberculosis lineages prevalent in Ethiopia: implications for tuberculosis treatment and management
di: Tesfaye Gebreyohannis Hailemariam, et al.
Pubblicazione: (2025-02-01)

Investigating the Antituberculosis Activity of Selected Commercial Essential Oils and Identification of Active Constituents Using a Biochemometrics Approach and In Silico Modeling
di: Katyna J. Boussamba-Digombou, et al.
Pubblicazione: (2022-07-01)

Correlation of <i>gyr</i> Mutations with the Minimum Inhibitory Concentrations of Fluoroquinolones among Multidrug-Resistant <i>Mycobacterium tuberculosis</i> Isolates in Bangladesh
di: Mohammad Khaja Mafij Uddin, et al.
Pubblicazione: (2021-11-01)

Antimycobacterial susceptibility evaluation of rifampicin and isoniazid benz-hydrazone in biodegradable polymeric nanoparticles against Mycobacterium tuberculosis H37Rv strain
di: Hakkimane SS, et al.
Pubblicazione: (2018-07-01)

Toxicological analysis and efficacy of 2-phenylchromone on mycobacteria viability and inflammatory response induced by Mycobacterium bovis
di: Flora Martinez Figueira Moreira, et al.
Pubblicazione: (2021-11-01)

Evaluation of the antibacterial effect of hydroalcoholic extract of the galls of Quercus infectoria on Aggregatibacter actinomycetemcomitans
di: Zohreh Tabibzadeh Noori, et al.
Pubblicazione: (2023-06-01)

Antibacterial Activity of Ricinus communis Extracts against Common Human Pathogens Obtained from Surgical Wound Infections in a Tertiary Care Hospital of Semi-urban Set-up at Andhra Pradesh, India
di: Archana Voleti, et al.
Pubblicazione: (2022-02-01)

Honey: Determination of volatile compounds, antioxidant and antibacterial activities
di: Semiramis Karlidag, et al.
Pubblicazione: (2021-06-01)

Determination of Antimicrobial Activity of Various Extracts of Stinging Nettle (Urtica dioica)
di: A Modarresi Chahardehi, et al.
Pubblicazione: (2012-05-01)

EFFECT OF HONEY FROM NORTH OF IRAN ON CANDIDA ALBICANS
di: S Mahdavi Omran,, et al.
Pubblicazione: (2008-12-01)

Effects of UV/H<sub>2</sub>O<sub>2</sub> Degradation on the Physicochemical and Antibacterial Properties of Fucoidan
di: Zhicheng He, et al.
Pubblicazione: (2024-05-01)

Investigations of Antibacterial Activity of Methanol and Aqueous Ex-tracts of the Body Wall of Sea Cucumber Holothuria leucospilota on some Human Pathogenic Bacteria
di: M. Nazemi, et al.
Pubblicazione: (2016-06-01)

High moxifloxacin cross-resistance levels among “newly identified” ofloxacin-resistant multidrug-resistant tuberculosis patients from South India: A ticking bomb or a tricky challenge?
di: Praveen Sanker, et al.
Pubblicazione: (2017-01-01)

Potential of diallyl sulfide from bulbs of Allium parvum to inhibit the growth and biofilm formation in Malassezia furfur MTCC 1374
di: Saravana P. KUMARI, et al.
Pubblicazione: (2024-03-01)

Potency of Eucalyptus Oil and Citronella Oil in Suppressing Virulence Factors of Xanthomonas oryzae pv. oryzae
di: Alifia Nur Ayusma, et al.
Pubblicazione: (2024-08-01)

Minimal Inhibitory Concentrations Of Azithromycin In Typhoidal Salmonella Isolated In Tertiary Care Setting
di: Anam Tariq, et al.
Pubblicazione: (2024-04-01)